Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $13,332 | 624 | 99.9% |
| Education | $15.65 | 1 | 0.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $1,260 | 64 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $1,061 | 59 | $0 (2024) |
| Takeda Pharmaceuticals U.S.A., Inc. | $761.46 | 51 | $0 (2024) |
| Merck Sharp & Dohme LLC | $610.64 | 24 | $0 (2024) |
| Celgene Corporation | $528.16 | 17 | $0 (2024) |
| Bayer Healthcare Pharmaceuticals Inc. | $493.35 | 25 | $0 (2024) |
| Janssen Biotech, Inc. | $483.57 | 12 | $0 (2024) |
| Eisai Inc. | $393.36 | 19 | $0 (2024) |
| Daiichi Sankyo Inc. | $356.11 | 16 | $0 (2024) |
| Amgen Inc. | $341.00 | 19 | $0 (2020) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $2,869 | 132 | Novartis Pharmaceuticals Corporation ($279.35) |
| 2023 | $2,886 | 121 | AstraZeneca Pharmaceuticals LP ($252.28) |
| 2022 | $1,799 | 72 | Janssen Biotech, Inc. ($169.12) |
| 2021 | $248.11 | 2 | Seagen Inc. ($125.00) |
| 2020 | $408.49 | 21 | Foundation Medicine, Inc. ($114.67) |
| 2019 | $1,580 | 85 | Takeda Pharmaceuticals U.S.A., Inc. ($196.06) |
| 2018 | $1,849 | 100 | Celgene Corporation ($288.79) |
| 2017 | $1,708 | 92 | Novartis Pharmaceuticals Corporation ($306.87) |
All Payment Transactions
625 individual payment records from CMS Open Payments — Page 1 of 25
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/30/2024 | ABBVIE INC. | ELAHERE (Drug) | Food and Beverage | In-kind items and services | $32.33 | General |
| Category: ONCOLOGY | ||||||
| 12/24/2024 | ADC Therapeutics America, Inc. | — | Food and Beverage | In-kind items and services | $22.55 | General |
| 12/19/2024 | Incyte Corporation | JAKAFI (Drug) | Food and Beverage | Cash or cash equivalent | $17.41 | General |
| Category: Hematology/Oncology | ||||||
| 12/18/2024 | BeiGene USA, Inc. | BRUKINSA (Drug) | Food and Beverage | In-kind items and services | $17.82 | General |
| Category: Oncology | ||||||
| 12/17/2024 | Takeda Pharmaceuticals U.S.A., Inc. | ALUNBRIG (Drug) | Food and Beverage | In-kind items and services | $27.51 | General |
| Category: ONCOLOGY | ||||||
| 12/11/2024 | Daiichi Sankyo Inc. | Enhertu (Drug) | Food and Beverage | In-kind items and services | $29.99 | General |
| Category: ONCOLOGY | ||||||
| 12/10/2024 | PFIZER INC. | INLYTA (Drug), PADCEV | Food and Beverage | In-kind items and services | $19.36 | General |
| Category: ONCOLOGY | ||||||
| 12/09/2024 | Merck Sharp & Dohme LLC | KEYTRUDA (Biological) | Food and Beverage | In-kind items and services | $30.98 | General |
| Category: ONCOLOGY | ||||||
| 12/05/2024 | PFIZER INC. | BOSULIF (Drug), ELREXFIO, ADCETRIS | Food and Beverage | In-kind items and services | $15.32 | General |
| Category: METABOLIC DISEASE;ONCOLOGY | ||||||
| 12/04/2024 | Novartis Pharmaceuticals Corporation | SCEMBLIX (Drug) | Food and Beverage | In-kind items and services | $28.79 | General |
| Category: Oncology | ||||||
| 12/03/2024 | PFIZER INC. | XTANDI (Drug), ORGOVYX, TALZENNA | Food and Beverage | In-kind items and services | $18.82 | General |
| Category: ONCOLOGY | ||||||
| 12/02/2024 | GlaxoSmithKline, LLC. | OJJAARA (Drug) | Food and Beverage | In-kind items and services | $20.25 | General |
| Category: ONCOLOGY | ||||||
| 11/21/2024 | ARRAY BIOPHARMA INC | BRAFTOVI (Drug), MEKTOVI, TUKYSA | Food and Beverage | In-kind items and services | $13.14 | General |
| Category: ONCOLOGY | ||||||
| 11/20/2024 | PUMA BIOTECHNOLOGY, INC. | — | Food and Beverage | In-kind items and services | $20.54 | General |
| 11/19/2024 | Novartis Pharmaceuticals Corporation | KISQALI (Drug) | Food and Beverage | In-kind items and services | $19.39 | General |
| Category: Oncology | ||||||
| 11/18/2024 | Genentech USA, Inc. | Tecentriq (Biological), Tecentriq Hybreza | Food and Beverage | In-kind items and services | $17.90 | General |
| Category: BioOncology | ||||||
| 11/14/2024 | TAIHO ONCOLOGY, INC. | LONSURF (Drug), INQOVI | Food and Beverage | In-kind items and services | $20.62 | General |
| Category: Oncology | ||||||
| 11/13/2024 | Bayer Healthcare Pharmaceuticals Inc. | Nubeqa (Drug), Xofigo | Food and Beverage | In-kind items and services | $25.98 | General |
| Category: Oncology | ||||||
| 11/13/2024 | Spectrum Pharmaceuticals Inc. | ROLVEDON (Drug) | Food and Beverage | In-kind items and services | $19.10 | General |
| Category: Oncology | ||||||
| 11/07/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | GILOTRIF (Drug) | Food and Beverage | In-kind items and services | $30.48 | General |
| Category: ONCOLOGY | ||||||
| 11/05/2024 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $17.71 | General |
| 11/04/2024 | PharmaEssentia USA Corporation | BESREMI (Drug) | Food and Beverage | In-kind items and services | $29.08 | General |
| Category: Oncology | ||||||
| 10/30/2024 | AstraZeneca Pharmaceuticals LP | CALQUENCE (Drug) | Food and Beverage | In-kind items and services | $19.89 | General |
| Category: Oncology | ||||||
| 10/29/2024 | Bayer Healthcare Pharmaceuticals Inc. | Stivarga (Drug), Vitrakvi | Food and Beverage | In-kind items and services | $23.83 | General |
| Category: Oncology | ||||||
| 10/22/2024 | Incyte Corporation | MONJUVI (Drug), PEMAZYRE | Food and Beverage | Cash or cash equivalent | $16.15 | General |
| Category: Oncology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 32 | 1,645 | 7,901 | $4.7M | $1.2M |
| 2022 | 34 | 1,650 | 8,367 | $4.5M | $1.1M |
| 2021 | 28 | 1,589 | 8,520 | $4.1M | $1.1M |
| 2020 | 32 | 1,521 | 8,881 | $4.4M | $1.1M |
All Medicare Procedures & Services
127 procedure records from CMS Medicare Utilization — Page 1 of 6
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| G6015 | Intensity modulated treatment delivery, single or multiple fields/arcs,via narrow spatially and temporally modulated beams, binary, dynamic mlc, per treatment session | Office | 2023 | 66 | 1,533 | $1.9M | $404,664 | 21.6% |
| 77014 | Ct guidance for insertion of radiation therapy fields | Office | 2023 | 96 | 1,464 | $512,400 | $132,225 | 25.8% |
| 77301 | High precision radiation therapy planning | Office | 2023 | 88 | 93 | $372,000 | $127,271 | 34.2% |
| 77373 | Cranial lesion surgery using radiation over multiple sessions | Office | 2023 | 24 | 130 | $410,540 | $96,092 | 23.4% |
| G6012 | Radiation treatment delivery,3 or more separate treatment areas, custom blocking, tangential ports, wedges, rotational beam, compensators, electron beam; 6-10 mev | Office | 2023 | 34 | 446 | $177,954 | $74,232 | 41.7% |
| 77427 | Radiation treatment management, 5 treatment sessions | Office | 2023 | 104 | 424 | $265,000 | $62,062 | 23.4% |
| G6017 | Intra-fraction localization and tracking of target or patient motion during delivery of radiation therapy (eg,3d positional tracking, gating, 3d surface tracking), each fraction of treatment | Office | 2023 | 31 | 532 | $152,684 | $42,990 | 28.2% |
| 77338 | Design and construction of radiation treatment device for high precision radiation therapy | Office | 2023 | 88 | 92 | $79,764 | $32,089 | 40.2% |
| 77336 | Continuing radiation therapy consultation per week | Office | 2023 | 129 | 458 | $104,424 | $28,692 | 27.5% |
| 77334 | Design and construction of complex radiation treatment device | Office | 2023 | 94 | 207 | $90,252 | $19,236 | 21.3% |
| 77300 | Calculation of radiation therapy dose | Office | 2023 | 126 | 317 | $62,132 | $15,645 | 25.2% |
| 77263 | Complex radiation therapy planning | Office | 2023 | 112 | 119 | $68,544 | $15,267 | 22.3% |
| 77290 | Obtaining data needed to develop the optimal radiation treatment, 3 or more treatment areas or any number of treatment areas where special treatment is involved | Office | 2023 | 45 | 46 | $55,568 | $15,003 | 27.0% |
| J9217 | Leuprolide acetate (for depot suspension), 7.5 mg | Office | 2023 | 16 | 103 | $160,680 | $13,605 | 8.5% |
| 77295 | 3d radiation therapy planning | Office | 2023 | 35 | 38 | $90,174 | $13,295 | 14.7% |
| 77435 | Management of cranial lesion surgery using radiation over multiple sessions | Office | 2023 | 23 | 25 | $40,550 | $12,212 | 30.1% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 65 | 65 | $21,710 | $10,452 | 48.1% |
| 78815 | Nuclear medicine study from skull base to mid-thigh with ct scan | Office | 2023 | 11 | 11 | $35,464 | $7,634 | 21.5% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 59 | 59 | $17,464 | $7,168 | 41.0% |
| 77293 | Obtaining respiratory data needed to develop the optimal radiation treatment | Office | 2023 | 23 | 23 | $25,024 | $7,100 | 28.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 75 | 105 | $9,660 | $5,779 | 59.8% |
| 77307 | Complex radiation therapy planning for delivery of external radiation | Office | 2023 | 15 | 21 | $23,478 | $4,552 | 19.4% |
| 77280 | Obtaining data needed to develop the optimal radiation treatment, 1 treatment area | Office | 2023 | 20 | 20 | $10,000 | $3,803 | 38.0% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 16 | 17 | $3,400 | $2,327 | 68.4% |
| 77333 | Design and construction of intermediate radiation treatment device | Office | 2023 | 17 | 18 | $5,568 | $1,855 | 33.3% |
About Dr. Kurt Meyer, M.D
Dr. Kurt Meyer, M.D is a Radiation Oncology healthcare provider based in Columbia, South Carolina. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/05/2011. The National Provider Identifier (NPI) number assigned to this provider is 1962799452.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Kurt Meyer, M.D has received a total of $13,347 in payments from pharmaceutical and medical device companies, with $2,869 received in 2024. These payments were reported across 625 transactions from 81 companies. The most common payment nature is "Food and Beverage" ($13,332).
As a Medicare-enrolled provider, Meyer has provided services to 6,405 Medicare beneficiaries, totaling 33,669 services with total Medicare billing of $4.6M. Data is available for 4 years (2020–2023), covering 127 distinct procedure/service records.
Practice Information
- Specialty Radiation Oncology
- Location Columbia, SC
- Active Since 07/05/2011
- Last Updated 06/07/2016
- Taxonomy Code 2085R0001X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1962799452
Products in Payments
- KEYTRUDA (Biological) $610.64
- NINLARO (Drug) $524.62
- CALQUENCE (Drug) $387.59
- ORGOVYX (Drug) $321.37
- KISQALI (Drug) $317.34
- ERLEADA (Drug) $309.41
- Lenvima (Drug) $294.48
- ENHERTU (Biological) $266.56
- TAGRISSO (Drug) $256.00
- INJECTAFER (Drug) $250.63
- Nubeqa (Drug) $245.22
- Lonsurf (Drug) $196.10
- PADCEV (Biological) $192.90
- JAKAFI (Drug) $183.67
- VERZENIO (Drug) $170.95
- Pomalyst (Drug) $170.32
- PEMFEXY (Drug) $168.09
- GILOTRIF (Drug) $153.61
- DOPTELET (Drug) $153.47
- SIR-Spheres Microspheres (Device) $148.78
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Radiation Oncology Doctors in Columbia
Mark Bryer, Md, MD
Radiation Oncology — Payments: $14,984
Reed Cope, Md, MD
Radiation Oncology — Payments: $9,236
Kevin Blas, M.d, M.D
Radiation Oncology — Payments: $8,859
Harold Johnson, Md, MD
Radiation Oncology — Payments: $7,964
Bo Lu, Md, Phd, MD, PHD
Radiation Oncology — Payments: $7,855
Leonid Zamdborg, M.d., Ph.d, M.D., PH.D
Radiation Oncology — Payments: $4,834